Thermi® in the News

Thermi Receives Notice Of Complete And Satisfactory Closure Of FDA’s “Vaginal Rejuvenation” InquiryIRVING, Texas, Nov. 15, 2018 /PRNewswire/ -- Thermi®, an Almirall, S.A. company, today announced that it has received a notice of completion to a U.S. Food and Drug Administration (FDA) inquiry on products used in "vaginal rejuvenation" procedures. Thermi received an "It has come to our attention" notice from the FDA on July 24, 2018 regarding specific claims about the company's ThermiVa® device in the United [...] Read more
This site is intended for US use.

©2020 ThermiGen, LLC. All rights reserved

Log in with your credentials

Forgot your details?